Zidovudine Tablet, Film Coated
Product Images NDC 65862-024

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zidovudine (NDC 65862-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zidovudine-fig1 (Zidovudine Fig1)

This is a description of Zidovudine Tablets, USP which contains 300mg. Each tablet contains 10mg of Zowas Us. The usual dosage is not mentioned but the recommendation is to consult a doctor for dosage and administration. There is information about the manufacturer's address which is Atovaquone, 270 Carson Business Park Drive, Carson, W 08520. There is also a reference to an over-printing zone coding area with a code of 5213.*

FDA Label Image

Zidovudine-fig2 (Zidovudine Fig2)

This is a description of a medication called Zidovudine. The medication comes in a film-coated tablet form with a dosage of 300mg per tablet. The recommended dosage for this medication is specified in the package insert. The package is child-resistant and contains 6 unit-dose packages, each with 10 tablets. The medication is distributed by Aurobindo Pharma USA, Inc. This medication should be stored at a temperature between 20°C and 25°C.*

FDA Label Image

Chemical Structure (Zidovudine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.